EcoDrugPlus

24-Dehydrocholesterol Reductase

Ensembl ID : ENSTRUG00000016297
Gene Symbol: DHCR24
1 Cross references
208 Possible Orthologues:

26s Proteasome Non-Atpase Regulatory Subunit 4-Like

Ensembl ID : ENSTRUG00000002109
Gene Symbol: LOC101067241
3 Cross references
220 Possible Orthologues:

26s Proteasome Regulatory Subunit 8

Ensembl ID : ENSTRUG00000005619
Gene Symbol: LOC101062380
4 Cross references
228 Possible Orthologues:

3-Hydroxy-3-Methylglutaryl-Coa Reductase

Ensembl ID : ENSTRUG00000013186
Gene Symbol: HMGCR
4 Cross references
195 Possible Orthologues:

3-Hydroxy-3-Methylglutaryl-Coenzyme A Reductase-Like

Ensembl ID : ENSTRUG00000018375
Gene Symbol: LOC101078757
3 Cross references
205 Possible Orthologues:

3-Phosphoinositide Dependent Protein Kinase 1

Ensembl ID : ENSTRUG00000015599
Gene Symbol: PDPK1
4 Cross references
221 Possible Orthologues:

40s Ribosomal Protein S5

Ensembl ID : ENSTRUG00000026426
Gene Symbol: LOC101061501
3 Cross references
263 Possible Orthologues:

40s Ribosomal Protein Sa

Ensembl ID : ENSTRUG00000004566
Gene Symbol: LOC101069505
4 Cross references
515 Possible Orthologues:

5'-Nucleotidase

Ensembl ID : ENSTRUG00000004739
Gene Symbol: LOC101065733
3 Cross references
180 Possible Orthologues:

5'-Nucleotidase Ecto

Ensembl ID : ENSTRUG00000014965
Gene Symbol: NT5E
1 Cross references
215 Possible Orthologues:

5-Hydroxytryptamine Receptor 1b

Ensembl ID : ENSTRUG00000004617
Gene Symbol: HTR1B
1 Cross references
181 Possible Orthologues:

5-Hydroxytryptamine Receptor 1b

Ensembl ID : ENSTRUG00000033288
Gene Symbol: HTR1B
3 Cross references
182 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).